| Group 6 Metals Limited (G6M) ORDINARY FULLY PAID |
Materials |
$6 |
G6M Reaches Agreement On Recapitalisation Plan
|
4 Dec 2024 8:46AM |
$0.025 |
$0.025 |
fallen by
0%
|
|
| Sg Fleet Group Limited (SGF) ORDINARY FULLY PAID |
Industrials |
- |
Scheme Implementation Deed
|
4 Dec 2024 8:45AM |
$3.330 |
$3.490 |
risen by
4.80%
|
|
SGF - Price-sensitive ASX Announcement
Full Release
Key Points
- SG Fleet enters into Scheme Implementation Deed with Westmann Bidco Pty Limited.
- Bidco to acquire 100% of SG Fleet shares at $3.50 per share.
- Total equity value of SG Fleet at approximately $1.227 billion.
- Offer represents a 31% premium over the closing share price as of 22 November 2024.
- SG Fleet Directors recommend shareholders vote in favor of the Scheme.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Benz Mining Corp (BNZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$316 |
BENZ SECURES OPTION OVER STRATEGIC GROUND
|
4 Dec 2024 8:45AM |
$0.350 |
$1.525 |
risen by
335.71%
|
|
BNZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Benz has secured an exclusive option to acquire highly prospective tenements adjacent to the Glenburgh Gold Project.
- The option secures over 20km of additional prospective strike adjacent to the Glenburgh Gold Project.
- Preliminary geological analysis suggests the ground covers the immediate extension of the prospective Glenburgh gneiss to the NE.
- The company will pay the Vendor A$5,000 for the option.
- Upon completion, Benz will issue 500,000 ordinary shares and grant a 0.75% net smelter royalty.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$68 |
Trading Halt
|
4 Dec 2024 8:43AM |
$0.215 |
$0.285 |
risen by
32.56%
|
|
CYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Cynata Therapeutics Limited has requested a trading halt.
- The halt is pending the announcement of phase 1 clinical trial results.
- The trading halt will last until either the announcement is made or normal trading resumes on December 6, 2024.
- Cynata is not aware of any reasons that would prevent the trading halt from being granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AUCyber Limited (CYB) ORDINARY FULLY PAID |
Information Technology |
$15 |
Trading Update and CEO Resignation
|
4 Dec 2024 8:42AM |
$0.200 |
$0.070 |
fallen by
65%
|
|
CYB - Price-sensitive ASX Announcement
Full Release
Key Points
- AUCyber Limited provides a trading update and announces CEO resignation.
- Unaudited revenue for four months to October 31, 2024 is $8.3 million.
- Underlying EBITDA loss is $(1.3) million.
- Company cash position is $5.7 million with no drawn debt.
- Post-merger performance is below expectations, with revenue 29% below budget.
- FY25 guidance has been withdrawn due to poor trading performance.
- Peter Maloney resigns as CEO, effective until March 2025 for transition assistance.
- The Board will seek external candidates for the CEO position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$102 |
AVITA Medical December 2024 Investor Presentation
|
4 Dec 2024 8:41AM |
$4.020 |
$1.185 |
fallen by
70.52%
|
|
| Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$70 |
New Copper Intersection 7.5km Along Strike from Comet-Ngami
|
4 Dec 2024 8:40AM |
$0.059 |
$0.150 |
risen by
154.24%
|
|
CBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cobre Limited announced details of the first completed exploration hole for 2024.
- Drill hole NCP55 intersected a 21m zone of chalcocite dominant mineralization.
- Mineralization increases from 0.3% to 3% chalcocite near the footwall.
- Results indicate further mineralization potential northeast of the Comet Target.
- Exploration target estimated between 103 and 166Mt at 0.38 to 0.46% Cu.
- Sample assays are expected in February 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$208 |
Clarification Ann - Over 95% gold recovery from Boundiali
|
4 Dec 2024 8:37AM |
$0.400 |
$0.605 |
risen by
51.25%
|
|
| 29Metals Limited (29M) ORDINARY FULLY PAID |
Materials |
$535 |
Proposed issue of securities - 29M
|
4 Dec 2024 8:36AM |
$0.370 |
$0.390 |
risen by
5.41%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$158 |
Update - Notification of buy-back - VVA
|
4 Dec 2024 8:35AM |
$1.360 |
$1.600 |
risen by
17.65%
|
|
| COSOL Limited (COS) ORDINARY FULLY PAID |
Information Technology |
$74 |
Toustone Acquisition Presentation
|
4 Dec 2024 8:35AM |
$0.960 |
$0.405 |
fallen by
57.81%
|
|
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
FDA Approval - Nitroglycerin Ointment
|
4 Dec 2024 8:34AM |
$0.045 |
$0.015 |
fallen by
66.67%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux's Nitroglycerin Ointment received FDA approval.
- The product is a generic version of Rectiv® Ointment.
- Indicated for moderate to severe pain from chronic anal fissures.
- Annual market sales for the product exceed USD 23 million.
- This is Acrux's sixth topical ANDA approved by the FDA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$27,856 |
PME Cleansing Notice - Sam Hupert
|
4 Dec 2024 8:33AM |
$256.730 |
$266.540 |
risen by
3.82%
|
|
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$283 |
Investment Return - November 2024
|
4 Dec 2024 8:33AM |
$1.290 |
$1.400 |
risen by
8.53%
|
|
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$27,856 |
PME Cleansing Notice - Anthony Hall
|
4 Dec 2024 8:33AM |
$256.730 |
$266.540 |
risen by
3.82%
|
|
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$27,856 |
Change of Director's Interest Notice - Sam Hupert
|
4 Dec 2024 8:31AM |
$256.730 |
$266.540 |
risen by
3.82%
|
|
| COSOL Limited (COS) ORDINARY FULLY PAID |
Information Technology |
$74 |
COSOL Grows Data Analytics Capability with Toustone
|
4 Dec 2024 8:31AM |
$0.960 |
$0.405 |
fallen by
57.81%
|
|
COS - Price-sensitive ASX Announcement
Full Release
Key Points
- COSOL acquires Toustone Pty Ltd for up to $22.44 million.
- Acquisition boosts COSOL's capabilities in enterprise asset analytics.
- Toustone specializes in predictive analytics and decision intelligence.
- Immediate earnings and EPS accretive to COSOL.
- Upfront consideration includes $8 million cash and COSOL shares.
- Additional payments dependent on Toustone meeting profit hurdles.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$27,856 |
Change of Director's Interest Notice - Anthony Hall
|
4 Dec 2024 8:31AM |
$256.730 |
$266.540 |
risen by
3.82%
|
|
| Trek Metals Limited (TKM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$43 |
Down-hole Televiewer Surveying at Christmas Creek
|
4 Dec 2024 8:30AM |
$0.021 |
$0.072 |
risen by
242.86%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$2,487 |
Update - Notification of buy-back - NEU
|
4 Dec 2024 8:29AM |
$13.390 |
$19.640 |
risen by
46.68%
|
|
| Lycaon Resources Limited (LYN) ORDINARY FULLY PAID |
Materials |
$8 |
Drilling Commenced at West Arunta
|
4 Dec 2024 8:29AM |
$0.230 |
$0.130 |
fallen by
43.48%
|
|
LYN - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling commenced at Stansmore project.
- Supported by up to $180,000 funding from Western Australian Exploration Incentive Scheme.
- Targeting significant magnetic anomaly.
- Potential for niobium-rare earth element deposits.
- Drilling expected to take 5-8 days.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peako Limited (PKO) ORDINARY FULLY PAID |
Materials |
$6 |
Peako Launches Investor Hub for Investor Engagement
|
4 Dec 2024 8:29AM |
$0.003 |
$0.004 |
risen by
33.33%
|
|
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$27,856 |
Sale of 1M shares each by founders
|
4 Dec 2024 8:29AM |
$256.730 |
$266.540 |
risen by
3.82%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- Co-founders sold 1 million PME shares each.
- Sale represents less than 4% of their respective holdings.
- Transaction conducted at closing market price of $256.73.
- Both founders retain over 24 million shares each.
- Combined shareholdings post-sale represent 46% of the company.
- Founders do not intend to sell further shares in the foreseeable future.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$118 |
Update - Notification of buy-back - SHJ
|
4 Dec 2024 8:28AM |
$0.885 |
$0.695 |
fallen by
21.47%
|
|
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$122,844 |
Update - Notification of buy-back - NAB
|
4 Dec 2024 8:25AM |
$39.600 |
$40.100 |
risen by
1.26%
|
|